Glucagon-like peptide-1 receptor agonist use and overall survival in endometrial cancer: a multicenter propensity score–matched cohort study. // Gynecologic Oncology. – URL: https://www.sciencedirect.com/science/article/pii/S0090825826022080?dgcid=rss_sd_all
Glucagon-like peptide-1 receptor agonist use and overall survival in endometrial cancer: a multicenter propensity score–matched cohort study. Gynecologic Oncology. https://www.sciencedirect.com/science/article/pii/S0090825826022080?dgcid=rss_sd_all
“Glucagon-like peptide-1 receptor agonist use and overall survival in endometrial cancer: a multicenter propensity score–matched cohort study.” Gynecologic Oncology.
@article{article98037,
title = {Glucagon-like peptide-1 receptor agonist use and overall survival in endometrial cancer: a multicenter propensity score–matched cohort study},
journal = {Gynecologic Oncology},
url = {https://www.sciencedirect.com/science/article/pii/S0090825826022080?dgcid=rss_sd_all}
}